Back
NVIDIA Vs. Akero Therapeutics Industry Stock Comparison
Buy
54
NVDA
NVIDIA
Last Price:
$134.30
Seasonality Move:
8.28%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$51.82
Seasonality Move:
-12.73%
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $51.79. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVDA Stock Price Chart
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $51.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
NVDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.99 | Buy |
Relative Strength Index (14 RSI): | 50.79 | Buy |
Chaikin Money Flow: | -200233824 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (123.7 - 140.96) | Buy |
Bollinger Bands (100): | (128.25 - 143.93) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.23 | Buy |
Relative Strength Index (14 RSI): | 65.31 | Buy |
Chaikin Money Flow: | -120893 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.17 - 57.71) | Buy |
Bollinger Bands (100): | (24.28 - 43.14) | Buy |
NVDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 136.41 | Sell |
20-day SMA: | 130.1 | Buy |
50-day SMA: | 134.56 | Sell |
200-day SMA: | 125.59 | Buy |
8-day EMA: | 135.89 | Sell |
20-day EMA: | 133.77 | Buy |
50-day EMA: | 134.19 | Buy |
200-day EMA: | 121.32 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.2 | Buy |
20-day SMA: | 51.13 | Buy |
50-day SMA: | 36.86 | Buy |
200-day SMA: | 28.92 | Buy |
8-day EMA: | 50.79 | Buy |
20-day EMA: | 47.87 | Buy |
50-day EMA: | 40.71 | Buy |
200-day EMA: | 31.81 | Buy |
NVIDIA Earnings Growth & NVDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.12 per share, an increase this year of $1.72 per share, and an increase next year of $1.48 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
NVIDIA Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |